Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Nabriva Therapeutics plcListing unverified | Other | $39.2 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $86.6 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $40.7 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $94 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $50 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $97.8 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $51.1 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $110.3 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $65.9 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $2.5K | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $128 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $127.1 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $61.4 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $90.8 | SEC | ||
Nabriva Therapeutics plcListing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $112.7 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $89.5 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $158.2 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $183 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $194 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $226.9 | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $2.4K | SEC | ||
Nabriva Therapeutics plcListing unverified | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Nabriva Therapeutics plcListing unverified | Exercise | n/a (No price was disclosed in the filing) | SEC | ||
Nabriva Therapeutics plcListing unverified | Other | $278.2 | SEC |